Sanofi Settles False Patent Marking Qui Tam Suit

Law360, New York (June 30, 2010, 2:34 PM EDT) -- Sanofi-Aventis US LLC has settled a suit brought by Promote Innovation LLC accusing the pharmaceutical giant of marking its anti-diuretic replacement therapy products with expired patents.

Judge David Folsom of the U.S. District Court for the Eastern District of Texas dismissed the case with prejudice Tuesday, one week after the companies agreed to settle the suit.

The terms of the settlement were not available Wednesday. Representatives for the companies did not immediately respond to requests for comment.

A company can be accused of false marking if...
To view the full article, register now.

Documents

Related

Sections

Law Firms

Companies

Patents

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.